# PharmaCyte Biotech, Inc.: Form SC 13D/A, filed Jun 23, 2022

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: SC 13D/A
- Filed: 2022-06-23
- Accepted by EDGAR: Jun 23, 2022, 15:40 ET
- Period: not reported
- Accession: 0000921895-22-002076
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000092189522002076/sc13da111375004_06232022.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000092189522002076/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000092189522002076/sc13da111375004_06232022.htm

Filed Jun 23, 2022.
Source: SEC EDGAR, the filing index for accession 0000921895-22-002076. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
